Concepts (68)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Education, Distance | 1 | 2022 | 34 | 0.790 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2022 | 146 | 0.730 |
Why?
|
| Education, Medical | 1 | 2022 | 175 | 0.700 |
Why?
|
| Students, Medical | 1 | 2022 | 243 | 0.660 |
Why?
|
| Sepsis | 3 | 2024 | 281 | 0.350 |
Why?
|
| Infant, Premature | 3 | 2024 | 174 | 0.280 |
Why?
|
| Neonatal Sepsis | 1 | 2024 | 2 | 0.240 |
Why?
|
| Bacterial Translocation | 1 | 2024 | 8 | 0.240 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2024 | 196 | 0.230 |
Why?
|
| Probiotics | 1 | 2024 | 41 | 0.220 |
Why?
|
| Vitamin D Deficiency | 1 | 2021 | 50 | 0.180 |
Why?
|
| Vitamin D | 1 | 2021 | 149 | 0.170 |
Why?
|
| Pandemics | 1 | 2022 | 608 | 0.140 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 2016 | 8 | 0.140 |
Why?
|
| Infant, Newborn | 3 | 2024 | 1311 | 0.120 |
Why?
|
| Microcirculation | 1 | 2014 | 50 | 0.110 |
Why?
|
| Gestational Age | 1 | 2013 | 183 | 0.110 |
Why?
|
| Drug Utilization | 1 | 2014 | 223 | 0.100 |
Why?
|
| Pediatric Obesity | 1 | 2013 | 93 | 0.100 |
Why?
|
| Skin Neoplasms | 1 | 2016 | 404 | 0.090 |
Why?
|
| Hospital Mortality | 1 | 2014 | 846 | 0.080 |
Why?
|
| Emergency Service, Hospital | 2 | 2014 | 1023 | 0.080 |
Why?
|
| Humans | 8 | 2024 | 59526 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 724 | 0.070 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2024 | 24 | 0.060 |
Why?
|
| Gram-Negative Bacteria | 1 | 2024 | 54 | 0.060 |
Why?
|
| India | 1 | 2024 | 157 | 0.060 |
Why?
|
| Feces | 1 | 2024 | 97 | 0.060 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2024 | 73 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2024 | 3101 | 0.050 |
Why?
|
| Female | 6 | 2024 | 30924 | 0.050 |
Why?
|
| Vitamins | 1 | 2021 | 83 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 673 | 0.040 |
Why?
|
| Seizures | 1 | 2021 | 118 | 0.040 |
Why?
|
| Male | 4 | 2024 | 27578 | 0.030 |
Why?
|
| Child | 2 | 2016 | 4306 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 2470 | 0.030 |
Why?
|
| Patient Acuity | 1 | 2014 | 18 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 2014 | 70 | 0.030 |
Why?
|
| Young Adult | 2 | 2014 | 4332 | 0.030 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2014 | 42 | 0.030 |
Why?
|
| Hypotension | 1 | 2014 | 47 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2014 | 70 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2014 | 256 | 0.030 |
Why?
|
| Birth Weight | 1 | 2013 | 83 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2014 | 143 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2014 | 279 | 0.030 |
Why?
|
| Adolescent | 2 | 2014 | 5932 | 0.030 |
Why?
|
| Linear Models | 1 | 2014 | 422 | 0.030 |
Why?
|
| Weight Gain | 1 | 2013 | 161 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2014 | 553 | 0.030 |
Why?
|
| Metabolic Syndrome | 1 | 2013 | 148 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 926 | 0.020 |
Why?
|
| United States | 2 | 2014 | 7514 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 1063 | 0.020 |
Why?
|
| Incidence | 1 | 2014 | 1238 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2013 | 886 | 0.020 |
Why?
|
| Infant | 1 | 2013 | 1527 | 0.020 |
Why?
|
| Biomarkers | 1 | 2014 | 1211 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2013 | 1839 | 0.020 |
Why?
|
| Aged | 2 | 2014 | 13346 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 2329 | 0.020 |
Why?
|
| Middle Aged | 2 | 2014 | 16279 | 0.020 |
Why?
|
| Adult | 2 | 2014 | 15791 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2014 | 1915 | 0.020 |
Why?
|
| Risk Factors | 1 | 2013 | 5017 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 5183 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2013 | 6011 | 0.010 |
Why?
|